_id	KpiId	KpiName	Value	DataType	Period	StartDate	EndDate	CollectionFrequency
1	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	37.50 %	Percentage	2010/2011	2010-04-01	2011-03-31	Quarterly
2	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	39.23 %	Percentage	2011/2012	2011-04-01	2012-03-31	Quarterly
3	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	30.89 %	Percentage	2012/2013	2012-04-01	2013-03-31	Quarterly
4	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	30.90 %	Percentage	2013/2014_Q1	2013-04-01	2013-06-30	Quarterly
5	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	34.60 %	Percentage	2013/2014	2013-04-01	2014-03-31	Quarterly
6	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	31.10 %	Percentage	2013/2014_Q2	2013-07-01	2013-09-30	Quarterly
7	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	30.50 %	Percentage	2013/2014_Q3	2013-10-01	2013-12-31	Quarterly
8	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	34.60 %	Percentage	2013/2014_Q4	2014-01-01	2014-03-31	Quarterly
9	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	40.10 %	Percentage	2014/2015	2014-04-01	2015-03-31	Quarterly
10	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	36.50 %	Percentage	2014/2015_Q1	2014-04-01	2014-06-30	Quarterly
11	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	35.60 %	Percentage	2014/2015_Q2	2014-07-01	2014-09-30	Quarterly
12	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	38.80 %	Percentage	2014/2015_Q3	2014-10-01	2014-12-31	Quarterly
13	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	40.10 %	Percentage	2014/2015_Q4	2015-01-01	2015-03-31	Quarterly
14	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	38.00 %	Percentage	2015/2016_Q1	2015-04-01	2015-06-30	Quarterly
15	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	31.10 %	Percentage	2015/2016	2015-04-01	2016-03-31	Quarterly
16	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	34.80 %	Percentage	2015/2016_Q2	2015-07-01	2015-09-30	Quarterly
17	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	33.30 %	Percentage	2015/2016_Q3	2015-10-01	2015-12-31	Quarterly
18	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	31.10 %	Percentage	2015/2016_Q4	2016-01-01	2016-03-31	Quarterly
19	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	38.08 %	Percentage	2016/2017	2016-04-01	2017-03-31	Quarterly
20	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	32.51 %	Percentage	2016/2017_Q1	2016-04-01	2016-06-30	Quarterly
21	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	37.93 %	Percentage	2016/2017_Q2	2016-07-01	2016-09-30	Quarterly
22	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	37.89 %	Percentage	2016/2017_Q3	2016-10-01	2016-12-31	Quarterly
23	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	38.08 %	Percentage	2016/2017_Q4	2017-01-01	2017-03-31	Quarterly
24	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	32.11 %	Percentage	2017/2018	2017-04-01	2018-03-31	Quarterly
25	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	36.93 %	Percentage	2017/2018_Q1	2017-04-01	2017-06-30	Quarterly
26	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	33.91 %	Percentage	2017/2018_Q2	2017-07-01	2017-09-30	Quarterly
27	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	29.96 %	Percentage	2017/2018_Q3	2017-10-01	2017-12-31	Quarterly
28	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	32.11 %	Percentage	2017/2018_Q4	2018-01-01	2018-03-31	Quarterly
29	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	30.33 %	Percentage	2018/2019_Q1	2018-04-01	2018-06-30	Quarterly
30	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	29.20 %	Percentage	2018/2019	2018-04-01	2019-03-31	Quarterly
31	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	26.61 %	Percentage	2018/2019_Q2	2018-07-01	2018-09-30	Quarterly
32	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	31.50 %	Percentage	2018/2019_Q3	2018-10-01	2018-12-31	Quarterly
33	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	29.20 %	Percentage	2018/2019_Q4	2019-01-01	2019-03-31	Quarterly
34	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	28.71 %	Percentage	2019/2020_Q1	2019-04-01	2019-06-30	Quarterly
35	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	32.49 %	Percentage	2019/2020_Q2	2019-07-01	2019-09-30	Quarterly
36	PHOF77	% of non-opiate users in treatment who successfully completed drug treatment (without representation within 6 months)	31.84 %	Percentage	2019/2020_Q3	2019-10-01	2019-12-31	Quarterly